By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Cybin Inc. Common Stock

Cybin Inc. Common Stock (HELP)

NASDAQ Market Data in USD, Fundamentals in CAD
$437.00
-$5.66
-1.28%
Last Update: 18 Jul 2026, 12:27
$15.21bn
Market Cap
-90.47
P/E Ratio (TTM)
Forward Dividend Yield
$307.84-$589.04
52 Week Range

HELP Stock Price Chart

Explore Cybin Inc. Common Stock interactive price chart. Choose custom timeframes to analyze HELP price movements and trends.

HELP Company Profile

Discover essential business fundamentals and corporate details for Cybin Inc. Common Stock (HELP) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

13 Sept 2019

Employees

50.00

CEO

Michael F. Cola

Description

Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.

HELP Financial Timeline

Browse a chronological timeline of Cybin Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 Aug 2026

EPS estimate is -$0.80.

Earnings released on 30 Jun 2026

EPS came in at -$0.96 surpassing the estimated -$1.04 by +7.89%.

Earnings released on 13 Feb 2026

EPS came in at -$0.72 falling short of the estimated -$0.53 by -35.85%.

Earnings released on 13 Nov 2025

EPS came in at -$1.39 falling short of the estimated -$0.74 by -87.84%.

Earnings released on 13 Aug 2025

EPS came in at -$1.10 falling short of the estimated -$0.96 by -14.72%.

Earnings released on 1 Jul 2025

EPS came in at -$1.01 falling short of the estimated -$0.85 by -18.70%.

Earnings released on 11 Feb 2025

EPS came in at -$0.37 surpassing the estimated -$0.73 by +49.52%.

Earnings released on 13 Nov 2024

EPS came in at -$2.86 falling short of the estimated -$0.98 by -190.85%.

Earnings released on 8 Aug 2024

EPS came in at -$0.12 surpassing the estimated -$0.97 by +88.02%.

Earnings released on 31 Mar 2024

EPS came in at -$0.17 .

Earnings released on 14 Feb 2024

EPS came in at -$0.24 surpassing the estimated -$1.22 by +80.45%.

Earnings released on 15 Nov 2023

EPS came in at -$0.05 .

Earnings released on 14 Aug 2023

EPS came in at -$0.06 .

Earnings released on 31 Mar 2023

EPS came in at -$0.07 .

Earnings released on 14 Feb 2023

EPS came in at -$0.06 .

Earnings released on 14 Nov 2022

EPS came in at -$0.06 .

Earnings released on 8 Aug 2022

EPS came in at -$0.07 .

Earnings released on 31 Mar 2022

EPS came in at -$0.10 .

Earnings released on 10 Feb 2022

EPS came in at -$0.10 .

Earnings released on 15 Nov 2021

EPS came in at -$0.11 .

Earnings released on 16 Aug 2021

EPS came in at -$0.09 .

HELP Stock Performance

Access detailed HELP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run